Pfizer sees COVID-19 vaccine revenue rise, expects to deliver 2.1 billion doses in 2021
Pfizer expects to deliver 2.1 billion doses of its COVID-19 vaccine in 2021, with plans to manufacture a total of 3 billion by the end of 2021.
Pfizer sees COVID-19 vaccine revenue rise, expects to deliver 2.1 billion doses in 2021
Pfizer expects to deliver 2.1 billion doses of its COVID-19 vaccine in 2021, with plans to manufacture a total of 3 billion by the end of 2021.
Comments
Post a Comment